KLK3 and prostate cancer: The studies presented herein have focused on asymptomatic men with a PSA < 20 ng/ml, as men with a PSA level > 20 ng/ml are more likely to harbour prostate cancer and are thereby less likely to pose a clinical diagnostic quandary.